In this advanced critical care pharmacology session, we compare major vasopressors and inotropes side by side — including norepinephrine, epinephrine, dopamine, phenylephrine, vasopressin, dobutamine, milrinone, methylene blue, hydroxocobalamin, oral midodrine, dopamine, and more.
Learn their mechanisms, receptor profiles, dosing, indications, and key differences in clinical use. We then test your knowledge with evidence-based practice questions to reinforce learning, perfect for exam preparation and real-world ICU application.
This is designed for critical care focused trainees, residents, advanced practice providers, ICU nurses, physicians, and other healthcare professionals looking to deepen their understanding of hemodynamic support agents.
What you’ll learn: Comparative mechanisms of common vasopressors and inotropes. When to choose one agent over another in different shock states. Dosing ranges, titration, and monitoring tips. Key adverse effects and contraindications. High-yield practice questions to test your knowledge.
Download our Vasopressor and Inotrope study guide and practice questions:
https://www.patreon.com/collection/1443765
Playlist Vasopressors and Inotropes:
https://youtube.com/playlist?list=PLf5bMa9_tvRg_nAnm91hsyHhI0y_ahoS1&si=Myz25vHJgHAp4Nvc
👇DON'T MISS OUT - JOIN OUR PATREON COMMUNITY TODAY 👇
https://www.patreon.com/WhiteBoardMedicine
DISCLAIMER THIS PODCAST DOES NOT PROVIDE MEDICAL ADVICE. The information, including but not limited to, audio, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read, watched, or listened to on this video, or any other videos, reports, texts tweets or other sources.